Your browser is no longer supported. Please, upgrade your browser.
ADMA ADMA Biologics, Inc. monthly Stock Chart
ADMA [NASD]
ADMA Biologics, Inc.
Index- P/E- EPS (ttm)-1.75 Insider Own0.40% Shs Outstand25.37M Perf Week-5.79%
Market Cap74.33M Forward P/E- EPS next Y-1.29 Insider Trans0.00% Shs Float20.51M Perf Month-12.54%
Income-24.50M PEG- EPS next Q-0.50 Inst Own34.60% Short Float0.19% Perf Quarter-21.02%
Sales12.30M P/S6.04 EPS this Y7.00% Inst Trans-1.02% Short Ratio1.08 Perf Half Y-35.75%
Book/sh1.69 P/B1.73 EPS next Y33.50% ROA-63.80% Target Price12.17 Perf Year-53.69%
Cash/sh1.01 P/C2.90 EPS next 5Y- ROE-794.70% 52W Range2.67 - 6.88 Perf YTD-42.77%
Dividend- P/FCF- EPS past 5Y3.70% ROI-110.40% 52W High-57.41% Beta2.09
Dividend %- Quick Ratio2.00 Sales past 5Y69.50% Gross Margin21.10% 52W Low9.74% ATR0.20
Employees92 Current Ratio2.80 Sales Q/Q47.80% Oper. Margin- RSI (14)42.24 Volatility6.56% 5.66%
OptionableNo Debt/Eq1.18 EPS Q/Q-10.90% Profit Margin- Rel Volume0.72 Prev Close2.97
ShortableYes LT Debt/Eq0.94 EarningsNov 10 AMC Payout- Avg Volume36.54K Price2.93
Recom2.00 SMA20-6.72% SMA50-8.24% SMA200-27.45% Volume26,316 Change-1.35%
Jan-23-17Upgrade Maxim Group Hold → Buy $13
Aug-01-16Downgrade Maxim Group Buy → Hold
Jul-25-16Reiterated Maxim Group Buy $24 → $14
May-13-15Reiterated Maxim Group Buy $18 → $24
Dec-08-14Initiated Oppenheimer Outperform $20
Dec-01-14Reiterated Maxim Group Buy $16 → $18
Oct-11-17 07:11AM  Marathon Asset Management and ADMA Biologics Complete $30 Million Debt Refinancing GlobeNewswire
Sep-28-17 10:08AM  ETFs with exposure to ADMA Biologics, Inc. : September 28, 2017 Capital Cube -10.70%
Sep-07-17 12:03PM  ETFs with exposure to ADMA Biologics, Inc. : September 7, 2017 Capital Cube
Sep-05-17 11:53AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2017 By the Numbers : September 5, 2017 Capital Cube
Aug-28-17 09:00AM  ADMA: Second Quarter 2017 Financial Results and Corporate Update Zacks Small Cap Research
Aug-23-17 07:38AM  ADMA Biologics to Present at Upcoming Investor Conferences GlobeNewswire
Aug-11-17 09:25PM  Adma Biologics reports 2Q loss Associated Press
04:15PM  ADMA Biologics Provides Corporate Update and Reports Second Quarter 2017 Financial Results GlobeNewswire
Jul-31-17 04:15PM  ADMA Biologics Strengthens Patent Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Methods GlobeNewswire
Jul-13-17 03:23PM  ETFs with exposure to ADMA Biologics, Inc. : July 13, 2017 Capital Cube
Jun-27-17 07:08AM  ADMA Biologics Provides Corporate Timeline and Activities Update to Stockholders GlobeNewswire +12.78%
Jun-06-17 03:33PM  ADMA Biologics Completes Acquisition of Biotests Therapy Business Unit Assets GlobeNewswire
Jun-05-17 01:59PM  ETFs with exposure to ADMA Biologics, Inc. : June 5, 2017 Capital Cube
Jun-02-17 10:28AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 2, 2017 Capital Cube
May-30-17 07:38AM  ADMA Biologics Stockholders Vote to Approve Acquisition of Certain Assets from Biotest Pharmaceuticals Corporation GlobeNewswire
May-25-17 04:15PM  ADMA Biologics to Present at Jefferies 2017 Healthcare Conference GlobeNewswire
May-19-17 03:00PM  ADMA: 1Q:17 Results and Biotest Acquisition: Valuation Implications Zacks Small Cap Research
May-12-17 04:08PM  Adma Biologics reports 1Q loss Associated Press
04:05PM  ADMA Biologics Provides Corporate Update and Reports First Quarter 2017 Financial Results GlobeNewswire
Apr-20-17 02:10PM  ETFs with exposure to ADMA Biologics, Inc. : April 20, 2017 Capital Cube
Apr-07-17 03:41PM  ETFs with exposure to ADMA Biologics, Inc. : April 7, 2017 Capital Cube
Mar-27-17 05:39PM  Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of ADMA Biologics, Inc. - ADMA PR Newswire
Mar-20-17 09:26AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube
09:26AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
Mar-14-17 03:01PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017 Capital Cube
03:01PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
Mar-02-17 01:04PM  ADMA BIOLOGICS, INC. Financials
Feb-24-17 04:37PM  ADMA Biologics Reports Year End 2016 Financial Results, Accomplishments and Upcoming Milestones GlobeNewswire
04:32PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
Feb-17-17 04:32PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jan-23-17 04:59PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Secu +7.91%
03:24PM  ADMA Biologics upgraded by Maxim Group
07:00AM  ADMA Biologics to Acquire Certain Assets from Biotest Pharmaceuticals Corporation and Become a Vertically Integrated Commercial Plasma Products Company GlobeNewswire
Dec-15-16 01:43AM  ADMA Biologics Inc (ADMA): Does It Stack Up To Its Peers? Insider Monkey
01:43AM  ADMA Biologics Inc (ADMA): Does It Stack Up To Its Peers? at Insider Monkey
Nov-21-16 10:15AM  ADMA: Incremental Progress on CMC Issue Resolution. Zacks Small Cap Research
Nov-16-16 12:32PM  ETFs with exposure to ADMA Biologics, Inc. : November 16, 2016
Nov-14-16 11:34AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 14, 2016
Nov-10-16 06:32PM  Adma Biologics reports 3Q loss
04:33PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:30PM  ADMA Biologics Reports Third Quarter 2016 Results GlobeNewswire
Oct-07-16 04:39PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial S
Sep-21-16 10:12AM  ETFs with exposure to ADMA Biologics, Inc. : September 21, 2016 Capital Cube
10:12AM  ETFs with exposure to ADMA Biologics, Inc. : September 21, 2016
Sep-09-16 04:56PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Sep-01-16 07:38AM  ADMA Biologics to Present at Upcoming Investor Conferences GlobeNewswire
Aug-17-16 12:15PM  ADMA - Reviewing 2Q:16 Results; Waiting for Clarity on Resubmission Timeline Zacks Small Cap Research -5.78%
Aug-16-16 10:45AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016 Capital Cube
10:45AM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q2, 2016 By the Numbers : August 16, 2016
Aug-12-16 04:47PM  Adma Biologics reports 2Q loss +6.39%
04:46PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:38PM  ADMA Biologics Reports Second Quarter 2016 Results GlobeNewswire
Aug-04-16 05:07PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
Aug-02-16 11:00AM  ADMA CRL Isolated to Partner Manufacturing Issues: Anticipate 8 Month Delay
Aug-01-16 06:56PM  INVESTOR NOTICE: Goldberg Law PC Announces an Investigation of Claims against ADMA Biologics, Inc. and Advises Investors with Losses to Contact the Firm Business Wire -17.32%
05:26PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Regarding Possible Violations of Federal Securities Laws by Certain Officers and Directors of ADMA Biologics, Inc. Business Wire
03:31PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of ADMA Biologics, Inc. (ADMA) PR Newswire
02:47PM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA PR Newswire
12:57PM  ADMA Biologics Inc (ADMA) Just Gave Us A CRL Opportunity at Insider Monkey
10:02AM  ADMA Biologics tanks 21% as Raymond James downgrades stock at MarketWatch
Jul-29-16 07:14PM  ADMA Biologics Receives Complete Response Letter from FDA for Pending Biologics License Application GlobeNewswire +7.39%
Jul-20-16 12:05PM  ETFs with exposure to ADMA Biologics, Inc. : July 20, 2016
Jun-16-16 07:38AM  ADMA Biologics to Present at the 2016 JMP Securities Life Sciences Conference GlobeNewswire
Jun-10-16 05:02PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote o
Jun-01-16 02:35PM  ADMA Biologics, Inc. :ADMA-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016
May-19-16 03:00PM  ADMA: Additional Capital Raised; Plasma Center Collections Escalating
May-13-16 05:20PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
05:16PM  Adma Biologics reports 1Q loss
05:05PM  ADMA Biologics Reports First Quarter 2016 Results GlobeNewswire
04:05PM  ADMA Biologics Further Enhances Cash Position by Securing $4.0 Million in Additional Capital Through Amended Loan and Security Agreement with Oxford Finance GlobeNewswire
May-06-16 09:51AM  Ally Financial Inc. (ALLY) and Two Other Companies Receive Vote Of Confidence from Management and Board at Insider Monkey
May-03-16 10:47AM  ADMA Biologics Announces Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
May-02-16 11:35AM  ADMA: Consistent Progress Toward RI-002 Approval
Apr-28-16 05:01PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendment or Waiver to Code of E -8.65%
09:15AM  ADMA Biologics Announces Pricing of Public Offering of Common Stock GlobeNewswire
Apr-27-16 04:37PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Other Events EDGAR Online
04:05PM  ADMA Biologics Announces Proposed Public Offering of Common Stock GlobeNewswire
Apr-12-16 07:38AM  ADMA Biologics Announces Data on RI-002 to be Presented at the Clinical Immunology Society 2016 Annual Meeting GlobeNewswire
Mar-29-16 05:12PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Mar-23-16 04:34PM  ADMA BIOLOGICS, INC. Files SEC form 10-K, Annual Report
04:34PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
04:27PM  ADMA Biologics Reports Year End 2015 Financial Results, Accomplishments and Upcoming Milestones GlobeNewswire
Mar-07-16 07:38AM  ADMA Biologics Announces Data Presented at 2016 American Academy of Allergy Asthma & Immunology Annual Meeting (AAAAI) GlobeNewswire
Mar-01-16 09:29AM  ADMA Biologics to Present at Cowen and Company 36th Annual Health Care Conference GlobeNewswire
Feb-24-16 07:38AM  ADMA Biologics Recognized as One of New Jerseys Best Places to Work 2016 GlobeNewswire
Feb-11-16 05:15PM  13G Filing: Consonance Capital Management and Adma Biologics, Inc. (ADMA) at Insider Monkey -6.67%
Feb-02-16 06:04AM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal
Dec-23-15 04:07PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Dec-21-15 12:22PM  ADMA Biologics, Inc. Earnings Analysis: Q3, 2015 By the Numbers
Dec-09-15 07:38AM  ADMA Biologics Expands Commercial Operations Team in Preparation for Commercial Launch of RI-002 in Second Half of 2016 GlobeNewswire
Dec-04-15 06:17PM  Biopharmaceutical Insider Buys Shares of ADMA Biologics
Dec-03-15 08:38AM  ADMA Biologics to Present at the Oppenheimer 26th Annual Healthcare Conference GlobeNewswire
Nov-26-15 11:55AM  Hedge Funds Are Dumping Manitex International, Inc. (MNTX) at Insider Monkey
Nov-22-15 01:13PM  This Is How DT Asia Investments Ltd (CADTU) Is Being Traded By Elite Investors at Insider Monkey
Nov-11-15 01:45PM  ADMA: Moving Forward with RI-002; On Track for Second Half 2016 Approval
Nov-10-15 04:59PM  Adma Biologics reports 3Q loss
04:53PM  ADMA Biologics Reports Third Quarter 2015 Results GlobeNewswire
04:19PM  ADMA BIOLOGICS, INC. Files SEC form 10-Q, Quarterly Report
04:17PM  ADMA BIOLOGICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
Nov-03-15 07:38AM  ADMA Biologics Announces Data to be Presented at the International Primary Immunodeficiencies Congress in Budapest Hungary GlobeNewswire
ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and prevention of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical study for the treatment of primary immune deficiency disease. The company also operates source plasma collection facilities in Norcross and Marietta, Georgia. ADMA Biologics, Inc. was founded in 2004 and is based in Ramsey, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Grossman Adam SPresident and CEOJul 13Option Exercise2.6842,021112,61645,732Jul 17 05:14 PM
Grossman Jerrold BDirectorJul 13Option Exercise2.6848,185129,136116,218Jul 17 05:13 PM
RICHMAN ERIC IDirectorJul 13Option Exercise2.682,8007,5046,300Jul 17 05:12 PM